Clinical Trial Update: Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing remimazolam besylate to propofol for deep sedation in critically ill patients, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Deep Sedation States

Drugs mentioned

• PROPOFOL (Propofol)
• Remimazolam besylate (remimazolam besylate)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Critically Ill, Deep Sedation | Phase 2 | Status: UNKNOWN